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Abstract 
Understudied, coinfections are more frequent in pig farms than single infections. In pigs, the term “Porcine Respira‑
tory Disease Complex” (PRDC) is often used to describe coinfections involving viruses such as swine Influenza A Virus 
(swIAV), Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and Porcine CircoVirus type 2 (PCV2) as well as 
bacteria like Actinobacillus pleuropneumoniae, Mycoplasma hyopneumoniae and Bordetella bronchiseptica. The clini‑
cal outcome of the various coinfection or superinfection situations is usually assessed in the studies while in most 
of cases there is no clear elucidation of the fine mechanisms shaping the complex interactions occurring between 
microorganisms. In this comprehensive review, we aimed at identifying the studies dealing with coinfections or 
superinfections in the pig respiratory tract and at presenting the interactions between pathogens and, when possible, 
the mechanisms controlling them. Coinfections and superinfections involving viruses and bacteria were considered 
while research articles including protozoan and fungi were excluded. We discuss the main limitations complicat‑
ing the interpretation of coinfection/superinfection studies, and the high potential perspectives in this fascinating 
research field, which is expecting to gain more and more interest in the next years for the obvious benefit of animal 
health.
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1 Introduction
Bacterial and viral respiratory diseases are a major health 
issue in species reared under confined conditions in 
large groups. Most often multiple infectious agents are 
involved in the development of these clinical conditions 
making unsuited the common reductionist approach 
of host–pathogen interactions by the study of single 
infection [1]. Infection by more than one type of patho-
gen (viruses, bacteria and parasites amongst others) is 
described as a mixed infection. However, the term coin-
fection is frequently used to describe concomitant infec-
tion of a cell or a host by separate pathogens [2]. Since 
in the literature the definitions of coinfection and mixed 
infection have been both used to describe the same 
events, we will use the term “coinfection” in the current 
review. Additionally, in virology, the term superinfec-
tion is used if one virus infects the cell or the host before 
infection by the second superinfecting virus. We will also 
use the term “superinfection” in the review. Finally, an 
opportunistic pathogen is usually considered as a patho-
gen that would not have infected animals in absence of 
the primary infection, or alternatively, “pathogen” that 
would have been asymptomatic in the absence of the pri-
mary infection. In some studies, however, the use of the 
terms “coinfection” is not suitable and “superinfection” 
should be used instead, as we will see later. This seman-
tic point is responsible for a lot of confusion and makes 
comparisons between studies sometimes tricky.
The outcome of any coinfection or superinfection can 
be affected by the interactions taking place between the 
infectious agents, the nature of the cell/host, adverse 
environmental and management conditions, intestinal 
and respiratory microbiomes, and the triggered immune 
response—innate and adaptive—developed afterwards 
[2, 3]. When occurring at the same time or with a delay, 
infections can impact the virulence of causative patho-
gens with subsequent consequences on the host immune 
response and its ability to clear the infections [2]. The 
first contact with a pathogen can change the cell/host 
response against any other second pathogen, possibly 
causing a more virulent infection, reducing its severity 
or suppressing it completely [4]. Thus, different scenarios 
concerning the pathogen interactions can be observed, 
the first infectious agent can promote the second one, 
attenuate its effects or simply prevent its establishment. 
Conversely, the second pathogen may also influence the 
first one directly or indirectly.
Coinfections have been described in both humans and 
animals [1, 2]. Moreover, bacterial and viral infections 
might be followed by secondary bacterial or viral infec-
tions, which in some cases are responsible for the pathol-
ogy development and the observed clinical signs. In this 
review, the current knowledge regarding frequent coin-
fections that occur in the porcine respiratory tract and 
particularly in the lungs are reviewed. When possible, we 
focused on the interactions between the mentioned path-
ogens and the various mechanisms justifying these inter-
actions and their consequences on the host’s response. 
We especially discussed coinfections involving main 
bacteria and viruses associated with the so-called por-
cine respiratory diseases, excluding coinfections involv-
ing parasites and fungi (including their metabolites, such 
as mycotoxins). Moreover, we do not discuss the impact 
of adverse environmental and management conditions 
which have been shown to be of major importance in the 
modulation of respiratory infections’ severity [3].
2  Porcine respiratory disease complex 
and the associated pathogens
Respiratory diseases have been formally described in 
pigs as early as the 1960′s [5] and several studies have 
been carried out to identify associated agents. The role 
of the infectious pathogens has been assessed by using 
two main approaches: direct research of the patho-
gens (by culture or Polymerase Chain Reaction—PCR 
for instance) from tissue samples of diseased (acute or 
chronic stage) and non-diseased pigs or indirect detec-
tion by serological tests to look for antibodies produced 
after exposure to specific pathogens. These studies indi-
cated that frequently under field conditions, several 
infectious pathogens are simultaneously detected from 
lung lesions (see [6–8] amongst others). Combinations 
of several infectious pathogens in particular bacteria and 
viruses frequently occur and are responsible for respira-
tory diseases in pigs reared under confined conditions 
in large communities [1]. However, the type of combina-
tions and associated infectious agents change over time 
with the emergence of new viral pathogens generally 
complicating disease severity [e.g. new strains of Porcine 
Reproductive and Respiratory Syndrome Virus (PRRSV), 
new types of Porcine CircoVirus (PCV), new strains of 
Porcine Respiratory alphaCoronaVirus (PRCoV) and new 
reassortants of swine Influenza A Virus (swIAV)].
Causative respiratory infectious agents can be divided 
into primary and secondary or opportunistic pathogens. 
Primary pathogen being defined here as pathogen that 
can infect the animal as first unique pathogen and then 
facilitate secondary or opportunistic coinfection. These 
primary pathogens include common bacteria such as 
highly virulent Actinobacillus (A.) pleuropneumoniae, 
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M. hyopneumoniae, Bordetella (B.) bronchiseptica in 
young piglets and common viruses such as swIAV [1]. 
PRRSV and PCV2 are not strictly respiratory pathogens 
as swIAV, however, since they also frequently affect the 
respiratory system and since they can act as facilitators 
of secondary respiratory infections, they must be con-
sidered too. Other primary pathogens such as Aujeszky’s 
Disease Virus (ADV) and PRCoV are reported but they 
are far less frequently encountered today or they have 
less impact on porcine health [1]. Then, some viruses 
like the porcine cytomegalovirus can also inhibit host 
immune functions—particularly the action of T lympho-
cytes—and promote respiratory diseases such as the por-
cine reproductive and respiratory syndrome [9]. Among 
the secondary pathogens common bacteria such as 
lower virulence strains of A. pleuropneumoniae, A. suis, 
Glaesserella parasuis, Pasteurella multocida, and Strep-
tococcus (S.) suis are reported. Together primary and 
secondary pathogens are involved in the “Porcine Res-
piratory Disease Complex” (PRDC) [10].
Several studies have assessed the nature of the infec-
tious agents directly or indirectly associated with respira-
tory diseases in pigs [7, 8, 11, 12]. In one of these studies 
involving breeding sows in five French farrow-to-finish 
herds [12], results indicated that S. suis, a secondary 
pathogen, was quite widespread among sows—67.1% of 
the animals being positive using a PCR assay—and PCV2 
and swIAV infections were highly prevalent (75% of the 
sows with antibodies against PCV2 and between 91.7% 
and 100% of the sows with antibodies against swIAV). 
Other infectious agents such as A. pleuropneumoniae, 
G. parasuis and P. multocida were detected in 31%, 25%, 
and 23% of the sows, respectively [12]. In another study 
evaluating infectious agents associated with respiratory 
diseases in 125 farrow-to-finish pig herds in France, it 
has been shown that M. hyopneumoniae, PRRSV, and 
swIAV subtype H1N1 were the major pathogens involved 
in pneumonia-like gross lesions [8]. For extensive pleu-
ritis, PRRSV was frequently associated with A. pleuro-
pneumoniae [8, 12]. Regarding bacteria associated with 
lung lesions in 3731 French slaughter pigs [8], a report 
mentioned lesions of pneumonia and pleuritis as the 
most frequent lesions. In these lesions, bacteria such as 
M. hyopneumoniae, P. multocida, A. pleuropneumoniae, 
S. suis, and G. parasuis were detected in 69.3%, 36.9%, 
20.7%, 6.4%, and 0.99% of the lungs, respectively [13]. In 
a retrospective analysis of the etiologic agents associated 
with respiratory diseases in pigs in USA, two or more 
infectious agents were identified in 88.2% of the analyzed 
cases [7]. PRRSV (35.4% of the samples), P. multocida 
(31.6%), M. hyopneumoniae (27%), swIAV (22.2%), G. 
parasuis (22.0%) and PCV2 (18.6%) were the infectious 
agents most frequently encountered [7]. In Korean pigs, 
PRRSV and PCV2 were frequently identified associated 
or not to various bacteria such as S. suis (25.2%), M. hyo-
pneumoniae (20.1%), P. multocida (12.9%), and A. pleuro-
pneumoniae (5%) [11].
Below we review the main primary pathogens as 
defined above, common viruses such as PRRSV, PCV2, 
swIAV, PRCoV and ADV as well as bacteria like A. pleu-
ropneumoniae, M. hyopneumoniae and B. bronchiseptica. 
Conversely, other pathogens involved in the PRDC are 
not presented in the following sections while considered 
in Additional file 1 presenting the different coinfections’ 
situations.
2.1  Porcine reproductive and respiratory syndrome virus
PRRSV is an enveloped single stranded positive RNA 
virus belonging to the Arteriviridae family. Two differ-
ent species, PRRSV-1 (also known as Betaarterivirus suid 
1), from European origin, and PRRSV-2 from American 
origin, are now distinguished [14]. This enveloped virus 
replicates mainly or exclusively in macrophages such as 
Alveolar Macrophages (AMs), but also macrophages 
from the nasal mucosa and Pulmonary Intravascular 
Macrophages (PIMs) [15, 16]. In  vitro, PRRSV can also 
replicate in cultured monocytes and monocyte-derived 
cells including macrophages [17] and in  vitro-derived 
Dendritic Cells (DCs) generated either from Bone Mar-
row hematopoietic cells (BMDCs) or blood Monocytes 
(MoDCs), depending on the in  vitro culture conditions 
[18, 19]. However, such in  vitro generated DCs are not 
representative of in vivo primary DCs which do not seem 
to be permissive to viral replication [20]. In fact, MoDC 
and BMDC (at least when generated using Granulo-
cyte Macrophage Colony-Stimulating Factor, GM-CSF) 
although possessing functional overlaps with the DC 
family, do not represent bona fide DCs, which represent 
an own lineage of hematopoietic cells distinct from the 
monocytic lineage [21]. Different cell surface molecules 
are involved in PRRSV entry and infection of cells: hep-
aran sulfate, porcine sialoadhesin—also known as sialic 
acid-binding immunoglobulin-type lectin 1 (Siglec-1), 
Siglec-10, CD151 and CD163 [22, 23]. Heparan sulfate 
is a GlycosAminoGlycan (GAG) that seems to play a 
modest or secondary role in PRRSV infection since the 
blocking of this receptor on AMs induced only a mild 
decrease in PRRSV infectivity. Moreover, this effect was 
not observed with all the PRRSV isolates tested, suggest-
ing that the involvement of heparan sulfate depends on 
the antigenic diversity of PRRSV [22]. Siglec-1/CD169 is 
a member of the sialic acid-binding lectins (Siglecs) fam-
ily and is expressed on macrophages [22] and Siglec-10 
has been identified as an alternative receptor to Siglec-1 
[23]. Binding of PRRSV to Siglecs induces its internali-
sation by clathrin-mediated endocytosis. Expression of 
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recombinant porcine sialoadhesin is sufficient to induce 
the internalisation of PRRSV by non-permissive cells, 
but not replication [24]. CD163 is a scavenger receptor 
involved in PRRSV infection [22]. Its expression on non-
permissive cells makes them susceptible to infection with 
PRRSV and allows productive replication of the virus 
[22]. Moreover, CD169-KO animals are still susceptible 
to PRRSV-2 infection [22], whereas CD163-KO animals 
are resistant to PRRSV-1 and PRRSV-2 [25, 26]. Finally, 
MYH9 has been recently identified as an indispensable 
partner of CD163 for PRRSV cell entry for both PRRSV-1 
and PRRSV-2 [27].
PRRS clinical signs can be nearly absent to severe 
depending on the considered PRRSV species and strains. 
When observed, there are, amongst the most frequent, 
lethargy, dyspnea, tachypnea, as well as a reproduc-
tive disease [16]. PRRSV can persist in infected pigs for 
several months after the initial infection particularly in 
lymphoid tissues and has the ability to alter the host’s 
immune system to escape it (for review see [16]). PRRSV 
interferes with the porcine innate immune response 
through downregulation of type I InterFeroNs (IFNs—
IFNα and IFNβ mostly), which are cytokines known for 
their antiviral properties [28]. PRRSV-infected mac-
rophages also had a reduced capacity to produce the 
pro-inflammatory cytokines TNFα and IL1β [28] and 
the production of the anti-inflammatory cytokine IL10 
was found enhanced during infection [29]. Nevertheless, 
the role of cytokine modulation during PRRS is unclear 
considering that the effects appeared to depend on the 
PRRSV species, as well as on the PRRSV isolates, since 
opposite results can be found with different PRRSV 
strains [30, 31]. In fact, some PRRSV-2 isolates were 
shown to enhance IFNα production while other PRRSV-1 
isolates suppressed it. Results seemed also very variable 
for the immunoregulatory IL10 along different isolates 
of PRRSV-1 [30, 31], making general conclusions about 
how PRRSV alters innate immune responses difficult. 
PRRSV impact on adaptive cellular immunity seems also 
to be highly variable according to the species and the 
strain [20]. Conversely, whereas non-protective antibody 
response against the viral nucleocapsid is found within 
a week post-infection, neutralizing antibodies appear-
ance is highly delayed for all PRRSV species and strains, 
appearing only after 3 or 4 weeks of infection and peak-
ing even later [16].
2.2  Porcine circovirus type 2
PCV2 is a naked circular single stranded DNA virus 
belonging to the Circoviridae family and responsible for 
Porcine CircoVirus Disease (PCVD). The attachment 
of PCV2 to target cells occurs through chondroitin sul-
fate B and probably other receptors [32]. Internalisation 
is not fully known but it does not seem to involve a spe-
cific receptor and the GAGs could mediate internalisa-
tion and binding to the target cells [33]. Most of the time 
the infection is subclinical but in some circumstances 
such as coinfections with other respiratory pathogens 
it can cause the Post-weaning Multisystemic Wasting 
Syndrome (PMWS), clinically characterized by wast-
ing respiratory disease, and enteritis [34]. Infection with 
PCV2 can occur in utero, resulting in stillborn piglets 
and mummified fetuses, or death at different ages after 
birth [34]. In young and older animals, PCV2 was found 
in cells expressing monocytes  (CD14+), and T and B 
cells  (CD4+,  CD8+,  IgM+) markers [35]. Further results 
showed that active replication of the virus was supported 
by T and B cells, with enhanced replication in prolifera-
tive cells [36]. In vitro, PCV2 can also infect many other 
cell types including endothelial cells, gut epithelial cells, 
fibrocytes, and DCs [37]. In DCs the virus seems to per-
sist and remain infective for a prolonged period without 
replication indicating that these cells might serve as a 
vehicle for virus spread in the host [38]. PMWS is char-
acterized by the depletion of lymphoid cells affecting T 
cells, B cells, and NK cells [39]. This lymphopenia was 
also associated with impaired responses of Peripheral 
Blood Mononuclear Cells (PBMCs) to mitogen stimu-
lation with lower levels of IL2, IFNγ, and IL4 produc-
tion compared to PBMCs from non-infected pigs [40]. 
Another feature of PMWS is an elevated level of IL10 
found in lymphoid organs, especially in the T cells rich 
areas [41]. IL10-mediated immunosuppression could play 
an important role in the PCV2 infection and the devel-
opment of PMWS. PCV2 has also the ability to alter the 
innate immune response [42]. Even though the virus 
does not productively infect DCs, evidence shows that it 
can interfere with the normal plasmacytoid DCs (pDCs) 
response. Upon stimulation with CpG-ODN, pDCs’ abil-
ity to produce IFNα and TNFα was impaired in cells 
previously infected with PCV2 [43]. PCV2 DNA isolated 
from infected cells induced the suppression of pDC IFNα 
production [43].
2.3  Swine influenza A virus
Influenza A viruses are enveloped single stranded nega-
tive RNA viruses belonging to the Orthomyxoviridae 
family. These enveloped viruses can infect a broad range 
of hosts, with pigs being one of their natural hosts (for a 
review see [44]). The three main IAV subtypes encoun-
tered in pigs are H1N1, H1N2, and H3N2 [44], but many 
genetic lineages and antigenic variants within these 
subtypes are co-circulating in the pig population world-
wide. Subclinical infections with swIAVs are common in 
pigs, but they can also induce a disease similar to what 
is observed in humans, with upper respiratory tract 
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distress associated with fever, cough, rhinitis, high mor-
bidity, and low mortality [44]. The main targets of swIAVs 
are epithelial cells of the respiratory tract but IAVs can 
also non-productively infect alveolar macrophages [45]. 
Two major glycoproteins are present at the surface of the 
virus: HemAgglutinin (HA) and NeurAminidase (NA). 
Binding of HA with the sialic acid molecules at the sur-
face of the host cells will induce the endocytosis of the 
viral particle [44]. The NA molecule plays the main role 
in the budding of the virus by removing the sialic acid, 
allowing the release of neoformed virus particles from 
the infected cell [44]. The innate response against the 
virus includes production of high levels of pro-inflam-
matory cytokines such as IFNα, TNFα, and IL6. DCs, in 
particular pDCs play an important role in this response 
[46]. An important observation was that the produc-
tion of these cytokines correlated to the viral loads and 
the severity of the disease. Infection with swIAV induces 
cellular and humoral specific immune responses in pigs 
recovering from the disease and the serum IgG and the 
mucosal IgA can protect the animal from re-infection 
[44]. NS1 and PA-X are the main viral proteins that alter 
the innate immune response, mainly by blocking the type 
I IFN response [47] as well as the NLRP3 inflammasome 
activation [48] in infected-epithelial cells and alveolar 
macrophages. Finally, the main mechanisms through 
which the swIAV escapes the adaptive host immune sys-
tem are the antigenic drift and the antigenic shift con-
cerning mainly HA and NA which are also the two major 
antigenic proteins expressed on the surface of the virus 
and against which the neutralizing humoral response is 
directed [44].
2.4  Porcine respiratory alphacoronavirus
PRCoV is an enveloped single stranded positive RNA 
virus belonging to the Coronaviridae family. In pigs, four 
Alphacoronavirus, one Betacoronavirus and one Delta-
coronavirus have been described [49, 50]. Thus, most of 
the porcine coronaviruses are from the genus Alphac-
oronavirus. The only respiratory porcine coronavirus, 
PRCoV, is a variant of Transmissible Gastroenteritis 
Virus (TGEV) where a large 5′ region deletion (nucleo-
tides 621–681) in the Spike gene of the virus altered 
the tropism and the virulence. Even if pigs have been 
shown to be susceptible to the first SARS-CoV (serolog-
ical evidence and isolation of the virus in a pig farm in 
the Xiqing County of Tianjin, China) [51] they have not 
been successfully experimentally infected, at this stage, 
by SARS-CoV-2 [52]. PRCoV uses aminopeptidase-
N (CD13) domain IV to enter cells [53] and replicates 
to high titers in the lungs (1 × 107–108 Tissue Culture 
Infectious Dose 50—TCID50) specifically in type 1 and 
2 pneumocytes. Moreover, it can infect epithelial cells 
of the nares, trachea, bronchi, bronchioles, alveoli, and, 
occasionally, alveolar macrophages [49]. Infections with 
the PRCoV are usually subclinical, but there is variation 
between strains and some can induce a more severe dis-
ease. PrCoV can infect pigs of all ages by direct contact 
transmission or aerosol [49]. The clinical signs are associ-
ated to the respiratory system and are mild to severe—
bronchointerstitial pneumonia—depending the strain 
and the context (environmental and management factors 
as well as the presence of other pathogens).
2.5  Aujeszky’s disease virus or PseudoRabies Virus (PRV)
Suid herpesvirus 1, usually known as PRV or ADV is 
the responsible agent of Aujeszky’s disease in pigs. It is a 
double stranded enveloped DNA virus from the Herpes-
viridae family and Alphaherpesvirinae subfamily target-
ing respiratory and/or genital mucosae for its replication 
[54]. ADV has a very broad host range varying from 
domestic animals like pigs, cattle, goats, sheep, cats and 
dogs to wild animals such as ferrets, foxes, hares, rac-
coons, and wild deer, and where it induces different dis-
eases [54]. Infected animals usually show fever, sneezing, 
coughing and vomiting accompanied occasionally with 
typical nervous manifestations like convulsions, aggres-
siveness and lack of coordination. Mortality rate can 
reach 100% in suckling piglets while in mature pigs the 
infection is inapparent or mild [54].
ADV possesses eleven types of envelope glycoproteins 
playing major roles in the interaction with host cells and 
the induction of immune response [54]. Viral binding and 
fusion with the plasma membrane of the target cell—epi-
thelial cells, neurons and alveolar macrophages—are con-
trolled by a cascade of events orchestred by glycoproteins 
C (gC), gB, gD, gH and gL. The binding process starts 
with an interaction of gC with heparin sulfate proteo-
glycans [54, 55]. Stabilization of this interaction is then 
assured by the binding of gD to specific cellular recep-
tors known as herpesvirus entry mediators such as HveA 
(TNFRSF14), HveB (PRR2, nectin 2), HveC (PRR1, nectin 
1), HveD (PVR, CD55), and 3-O-sulfated heparin sulfate 
[54, 56]. At this stage, Tyrosine-based or dileucine-based 
endocytosis in parallel with clathrin-mediated endocyto-
sis occur by the mediation of gB, gH and gL, leading to 
the penetration of the capsid and the tegument into the 
cellular cytoplasm. Finally, the interaction of the capsid 
with dynein leads to the release of viral DNA into the cel-
lular nucleus after a transport along microtubules from 
the periphery to the nuclear pores [55].
Porcine humoral immune response is induced by ADV 
and neutralizing antibodies are mainly directed against 
gC [57]. Specific cell mediated immune responses are 
also triggered and MHC class I restricted, gC-specific, 
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cytotoxic cells are induced. ADV also alters the IFN sign-
aling pathway by suppressing STAT1 tyrosine phospho-
rylation leading to an inhibition of IFN-Stimulated Genes 
(ISGs) expression [54, 57].
ADV may be involved in the PRDC and can be isolated 
alone or with other pathogens. Accordingly, a study con-
ducted in Taiwan reported the association of ADV with 
PCV2 in 10.3% of the evaluated pigs using a multiplex 
PCR [58].
2.6  Actinobacillus pleuropneumoniae
Animals affected with this Gram negative bacterium 
develop a pleuropneumonia characterized by fibrinohe-
morrhagic necrotizing bronchopneumonia and fibrinous 
pleuritis which can reach a high mortality rate [59, 60]. 
Although the disease is best known in its acute/peracute 
forms, subacute and/or chronic presentations with low or 
no mortality are highly prevalent, especially in the pres-
ence of antibiotic treatments. Many herds are subclini-
cally infected without previous or present episodes of 
clinical disease and in the absence of suggestive lesions 
at the slaughter house. Animals are, nevertheless, carri-
ers of the pathogen. This happens in several conventional 
herds which may be simultaneously infected not only 
with several low/intermediate virulent strains, but also, 
in some cases, with strains highly likely to cause disease. 
In the latter case, outbreaks may suddenly appear in the 
presence of concomitant diseases or as a consequence 
of changes in management and/or environment [59, 60]. 
Eighteen serotypes of the bacterium have been described, 
which can all induce disease, although clear differences 
in virulence have been described [59, 60]. These bac-
teria can be found mainly in tonsils of carrier animals; 
virulent strains have a tropism for the lower respiratory 
tract where they preferentially bind to ciliated cells of the 
terminal bronchioli and pneumocytes [59, 60]. Different 
virulence factors expressed by A. pleuropneumoniae are 
involved in the colonization and the development of the 
disease. Adhesion to cells could be mediated by type IV 
fimbriae that are expressed upon contact with respiratory 
epithelial cells in vitro and during lung infection [59, 60]. 
Adhesion of A. pleuropneumoniae to respiratory epithe-
lial cells also involves the binding of bacterial lipopoly-
saccharides to glycosphingolipids on the surface of the 
cells [59, 60]. The formation of biofilm by the bacteria is 
likely to play an important role in the colonization of the 
host [61]. After attachment to the target cells, the bac-
teria can produce four different pore-forming exotoxins 
(Apx I, II, III and IV) inducing the lysis of alveolar epi-
thelial cells, thus allowing the acquisition of nutrients 
by the bacteria, but also participating in the develop-
ment of the lesions [60, 62]. Some of the virulence fac-
tors expressed by A. pleuropneumoniae interfere with 
the host’s immune response. The toxins Apx I, II and III 
induce the lysis of not only respiratory epithelial cells, 
but also of cells involved in the innate immune response 
such as macrophages and neutrophils [60, 63]. At lower 
concentrations, these toxins lose their lytic properties but 
can still impair macrophages chemotactic activity and 
their phagocytic abilities [64]. The capsular polysaccha-
rides of A. pleuropneumoniae interfere with macrophage 
phagocytosis and enable resistance to complement-medi-
ated killing [60]. A. pleuropneumoniae may also interfere 
with the antibody response by producing proteases that 
can degrade porcine IgA and IgG [59, 60].
2.7  Mycoplasma hyopneumoniae
This cell wall-free bacterium is considered to play a pri-
mary role in PRDC and is the causative agent of porcine 
Enzootic Pneumonia (EP), a disease with high morbid-
ity but low mortality rates [65]. The main pathological 
mechanisms involved in M. hyopneumoniae infections 
are: (i) adhesion to the ciliated cells of the tracheal epi-
thelium inducing ciliostasis, loss of cilia and exfoliation, 
dysregulation of cellular homeostasis (with increased 
intracellular calcium concentration) and secretion of 
cytotoxic factors, (ii) alteration of the mucociliary tract, 
(iii) inflammatory reactions sometimes exacerbated and 
prolonged, and (iv) manipulation of the innate and adap-
tive immune responses [65, 66]. Among the adhesins 
described in M. hyopneumoniae, P97 is reported to be 
a major determinant of cell adhesion [65–67]. Several 
other adhesins were reported: P102 linked to P97, LppS, 
LppT, MgPa, P65, P76, P110, P146, P159, and P216 [65, 
66]. Most adhesins are transcribed and translated dur-
ing M. hyopneumoniae infection and then undergo post-
translational cleavage to result in diverse products on the 
membrane surface [65, 67, 68]. The diversity of surface 
proteins can also derive from the variation in the num-
ber of repeats in genes encoding adhesins [69]. These 
mechanisms of antigenic variation enable the bacterium 
to escape from immune system recognition and to invade 
the host [66]. Adhesins can also recruit extracellular 
matrix components (plasminogen, fibronectin and actin 
amongst others), and therefore can promote invasion and 
inflammatory response [65, 70].
The immune response induced against M. hyopneu-
moniae, may have a double action: over-activation of the 
local immune response resulting in a pathologic inflam-
matory reaction or local immunosuppression explaining 
the chronic nature of the associated pathologies [65, 66]. 
Acute M. hyopneumoniae infection leads to the recruit-
ment and activation of various innate immune cells, 
essentially through the involvement of a large range 
of cytokines: IL1, IL6 and TNFα in lungs; CXCL8, IL1, 
IL2, IL4, IL6, TNFα and IL10 in Bronchus-Associated 
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Lymphoid Tissue (BALT) or TracheoBronchial Lavage 
Fluid (TBLF) [65, 71, 72]. Some of these inflammatory 
cytokines (TNFα, CXCL8, IL1β, IL6) are produced chron-
ically in the lungs and play powerful roles in apoptosis 
(TNFα), differentiation and chemotaxis of neutrophils 
(respectively, IL6 and IL8), and macrophage activation 
(TNFα, IL1β). Chronic infections are typically associated 
with intense lymphoid hyperplasia [71] and are charac-
terized by an accumulation of IgG- and IgA-expressing 
plasma cells,  CD4+ T cells, macrophages and DCs in the 
BALT of inflamed lung tissue [73]. Involvement of T cell 
activation in chronic inflammation is also supported by 
the presence of T-cell cytokines such as IL-2 and IL-4 in 
bronchoalveolar exudates [72].
In vitro studies conducted with macrophages co-
cultured with M. hyopneumoniae highlighted a strong 
activation of inflammatory pathways inducing the pro-
duction of cytokines and chemokines, and expression 
of receptors or pathways inducing cell apoptosis [65, 66, 
74, 75]. Moreover, M. hyopneumoniae is described as an 
inhibitor of macrophages phagocytic activity, which may 
explain the chronicity of M. hyopneumoniae infections 
and the greater host susceptibility to other pathogens [65, 
66, 74].
Mycoplasma hyopneumoniae was found to activate co-
stimulatory molecule expression on bona fide DCs with 
poor TNFα production, contrasting with monocytes. 
Interestingly, a strong mitogenic activity for B cells was 
observed [76]. Altogether, these data indicate that M. 
hyopneumoniae is well sensed by the innate immune sys-
tem, but the presence of immune evasion mechanisms 
targeting antigen presenting cells remains a possibility 
that needs further investigations.
Antibody responses after infection develop slowly and 
do not appear to correlate with protection [65, 66]. The 
literature on M. hyopneumoniae infections coupled with 
information from mouse models indicates that adaptive 
immune responses represent a fragile balance between 
pathogenic and protective Th- cell responses, probably 
belonging to the Th1 or Th17 types [65, 66].
2.8  Bordetella bronchiseptica
This aerobic Gram-negative bacterium can be found 
in the respiratory tract of several animal species and it 
presents a worldwide distribution in the porcine rearing 
[77]. B. bronchiseptica has a strong tropism for ciliated 
cells from the respiratory tissue and is mostly detected in 
the apical portion of the ciliated cells of turbinates, tra-
chea and lungs [77, 78]. It can also be found in the cyto-
plasm of neutrophils and macrophages and rarely in the 
alveolar lumen associated with small tufts of cilia [77, 
78]. Hence, infected pigs show cilia loss in the bronchial 
and bronchiolar epithelium associated with multifocal 
erosion, fibrosis, and hyperplasia. Neutrophil infiltrates 
are noted in the peri-conchal meatus and the submucosa 
of the bronchioles and alveoli, while lymphocyte and 
plasma cell infiltrations occur at the level of the lamina 
propria [77, 78].
Cell adhesion of B. bronchiseptica is a multifactorial 
process involving two main virulence factors; Filamen-
tous HemAgglutinin (FHA) and PeRtactiN (PRN) [77, 
79]. The expression of both adhesins is controlled by the 
Bordetella virulence genes (Bvg)AS signal transduction 
system. FHA is an adhesin with several binding domains 
including a carbohydrate- recognition domain responsi-
ble of the adhesion to macrophages and ciliated epithe-
lial cells, a heparin-binding domain that mediates the 
binding to sulfated polysaccharides, and an Arg-Gly-Asp 
domain (RGD) regulating the InterCellular Adhesion 
Molecule 1 (ICAM1) by epithelial cells after interac-
tion with the NF-κB signalling pathways [79]. This RGD 
domain is also present in the structure of PRN and con-
tributes to the binding process [77, 79]. On the other 
hand, non-opsonic adhesion mechanisms play a role in 
binding to the host cells such as carbohydrate-specific 
mechanisms and those involving sialic acid-containing 
compounds [77].
Virulence of the bacteria depends on the strains; there-
fore, clinical signs can be different going from sneezing 
and transient nasal discharge for moderate and non-toxic 
strains to bronchopneumonia and atrophy of the nasal 
turbinate bones for virulent strains, especially if they are 
associated to other bacteria such as P. multocida [77]. 
Thus, B. bronchiseptica is usually described as primary 
lung pathogen in young pigs where it causes necrohem-
orrhagic bronchopneumonia whereas in older pigs this 
bacterium is mostly known as an opportunistic pathogen 
contributing to the PRDC [77]. The immune response 
against B. bronchiseptica is mainly triggered by the differ-
ent toxins expressed such as adenylate cyclase, tracheal 
cytotoxin and DermoNecrotic Toxin (DNT).
3  Coinfections and superinfections 
and the resultant consequences for the porcine 
host
3.1  Selection and exclusion criteria for considered studies
In the following section and Additional file  1, we have 
used the published studies evaluating multiple infections 
including viral-viral, bacterial-viral, viral-bacterial and 
bacterial-bacterial respiratory coinfections and super-
infections in swine. Both in  vivo and in  vitro studies 
comparing single to multiple infections were included. 
Studies evaluating vaccinations and the development 
of diagnostic techniques such as ELISA or qPCR were 
excluded as well as trials testing antiviral or antibacterial 
molecules when there was no clear comparison between 
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single and multiple infections. An attempt to present 
a synthetic view of coinfections is depicted in the heat 
maps (see Figures 1, 2, 3). However, we recommend read-
ers to refer to Additional file 1 for each coinfection cou-
ple to get a more detailed view.
In these heat maps, we were interested in the effect of 
the first pathogen on the multiplication of the second 
one (named “assessed pathogen” in the figures) and on 
the host immune response and/or clinical signs. These 
effects were evaluated and a grade from − 5 to + 5 was 
given to every pathogen depending on the intensity of 
its impact on the multiplication of the second agent and 
on the immune response or on the clinical signs. Nega-
tive grades were given to pathogens decreasing the mul-
tiplication of other pathogens, while positive grades were 
given to those inducing an increase. Similarly, negative 
grades were attributed to pathogens with a tendency to 
decrease clinical signs or immune response related to 
the other pathogen. Positive grades were given in case 
of an increase. The sum of the grades was calculated if 
the same pathogen combination was evaluated in sev-
eral studies except in the case of discordant results. This 
grading was represented in the following heat maps and 
the number of the identified studies for the same patho-
gen combination is shown on the maps. In the heat maps, 
other pathogens, that are less associated to PRDC such as 
G. parasuis, M. hyorhinis, M. floculare, P. multocida, and 
S. suis or even not considered as respiratory pathogens 
like Staphylococcus aureus, Classical Swine Fever Virus, 
Hepatitis E Virus, Porcine RubulaVirus, PPV, and Torque 
Teno sus Virus 1 have also been included. Indeed, these 
pathogens can also impact the outcome of respiratory 
infections and deserve, at least, to be mentioned.
3.2  The different types of coinfections
3.2.1  Virus–virus
Viral/viral respiratory coinfections have always had an 
important role in the porcine respiratory disease com-
plex [1]. Several studies assessed the presence of two or 
more viral pathogens in pigs showing respiratory clini-
cal signs in farms located in endemic regions [7, 8, 13]. 
The main viruses contributing to the porcine respiratory 
disease are swIAV, PRRSV, PCV2, and to a lower extent 
the PRCoV and the ADV. Due to their fast-spreading and 
Figure 1 Impact of coinfection on multiplication/replication of the microorganisms. Heat maps depicting: A the impact of a secondary 
viral infection (top) on the replication of the virus (side) responsible of the primary infection in virus‑virus dual infections (coinfections and 
superinfections) in vitro (up) and in vivo (down). B the impact of a bacterial infection on the replication of the infecting virus in virus‑bacterium 
dual infections (coinfections and superinfections) in vitro (up) and in vivo (down). C the impact of a viral infection on the multiplication on the 
infecting bacteria in virus‑bacterium dual infections (coinfections and superinfections) in vitro (up) and in vivo (down). D the impact of a secondary 
bacterial infection (top) on the multiplication of the bacteria (side) responsible of the primary infection in bacterium‑bacterium dual infections 
(coinfections and superinfections) in vivo. The numbers shown on the maps correspond to the number of the identified studies for the same 
pathogen combination (see Additional file 1A and B). PRRSV: Porcine Reproductive and Respiratory Syndrome Virus, swIAV: swine Influenza A Virus, 
PCV2: Porcine Circovirus type 2, ADV: Aujeszky’s Disease Virus, PRCoV: Porcine Respiratory alphaCoronaVirus, CSFV: Classical Swine Fever Virus, HEV: 
Hepatitis E Virus, PorPV: Porcine RubulaVirus, PPV: Porcine ParvoVirus.
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their economic consequences, some viruses were more 
studied than others in the last 20 years, especially PCV2, 
PRRSV, and swIAV as shown in Additional file 1A and B. 
We will thus put more emphasis on these three viruses as 
causes of primary infections.
Many in  vivo studies were carried out to assess the 
severity of the clinical signs and the development of the 
microscopic/macroscopic lesions. This approach ena-
bled a comparison between coinfection/superinfection 
and single-infection conditions. Then, viral interference 
was progressively more frequently measured as a way 
to better understand the consequences of coinfections. 
In the last decades, the strong development of molecu-
lar biology and various tools enabled the evaluation of 
the immune response developed following polyviral 
infections.
In Additional file 1, the selected studies that were car-
ried out on viral coinfections are presented from the old-
est in vivo experiments to the latest in vitro and ex vivo 
experiments (Additional file 1A and B). This data synthe-
sis highlights the major impact of PRRSV primary infec-
tion, which can both increase the titre of the following 
virus (PCV2, Hepatitis E Virus—HEV) in vitro [80] and 
in vivo [81–83] (Figure 1A), but can also worsen the clini-
cal score associated to the disease (Figure 3A). Interest-
ingly, even when the PRRSV does not increase the viral 
production of the other virus, as observed in coinfections 
Figure 2 Impact of coinfection on inflammation. Heat maps 
depicting: A the impact of dual virus‑virus infections (coinfections 
and superinfections) and B the impact of virus‑bacterium infections 
(coinfections and superinfections) on the immune response of 
hosting cells (in vitro). The numbers shown on the maps correspond 
to the number of the identified studies for the same pathogen 
combination (see Additional file 1). PRRSV: Porcine Reproductive 
and Respiratory Syndrome Virus, swIAV: swine Influenza A Virus, 
PCV2: Porcine Circovirus type 2, PRCoV: Porcine Respiratory 
alphaCoronaVirus, CSFV: Classical Swine Fever Virus.
Figure 3 Impact of coinfection on clinical signs. Heat map depicting: A the clinical impact of dual virus‑virus infections (coinfections 
and superinfections), B the clinical impact of virus‑bacterium infections (coinfections and superinfections) and C the clinical impact of 
bacterium‑bacterium infections (coinfections and superinfections) on the developed clinical signs (in vivo). The numbers shown on the 
maps correspond to the number of the identified studies for the same pathogen combination (see Additional file 1). M. hyop: Mycoplasma 
hyopneumoniae, A. pleuro: Actinobacillus pleuropneumoniae, B. bronchi: Bordetella bronchiseptica, P. multo: Pasteurella multocida, PRRSV: Porcine 
Reproductive and Respiratory Syndrome Virus, swIAV: swine Influenza A Virus, PCV2: Porcine Circovirus type 2, ADV: Aujeszky’s Disease Virus, PRCoV: 
Porcine Respiratory alphaCoronaVirus, HEV: Hepatitis E Virus, PorPV: Porcine RubulaVirus, PPV: Porcine ParvoVirus, TTsuV1: Torque Teno sus Virus 1.
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involving swIAV [84] or PRCoV [85] (Figure  1A), it can 
also worsen the associated clinical signs. SwIAV and 
PCV2 as primary infectious agents have been less stud-
ied. However, it can be observed that swIAV can interfere 
with other virus productions (PRRSV and PRCoV) [85, 
86] whereas PCV2 has some detrimental impact on the 
clinical outcome of secondary viral infections (PRRSV, 
swIAV, and PPV) [87–89] (see Additional file 1 and Fig-
ure  1A). Then, regarding the inflammation induced in 
coinfection conditions, various outcomes were observed 
depending which viruses were considered (Figure 2A).
3.2.2  Bacterium–virus and virus–bacterium
Many in  vitro and in  vivo experiments, with different 
bacterium-virus and virus-bacterium combinations, have 
been performed to identify the underlying mechanisms 
of the PRDC (see Figures 1B, C, 2B, C, and 3B). The main 
studies are presented in Additional file 1C and D.
Bacterium-viral coinfections can also involve various 
primary respiratory pathogens. Among them, the most 
frequently studied bacterium is M. hyopneumoniae, a 
pathogen that induces a chronic respiratory disease and 
can influence the outcome of a subsequent viral infec-
tion. However, mycoplasma infection needs to be already 
well established in the respiratory tract at the time of the 
viral infection to potentiate it. Indeed, M. hyopneumo-
niae inoculated to pigs simultaneously or shortly before 
the virus did not strongly impact the severity of the viral 
infections (PCV2, swIAV, PRRSV) [90–92], while its 
impact was clearly evidenced when inoculated 3  weeks 
before viral infections [93].
It is well-known that viral infections can induce an ideal 
environment for a bacterial superinfection through dif-
ferent mechanisms such as the destruction of the epithe-
lial barrier, the over-expression of the receptors involved 
in the bacterial adhesion to the cells, and the alteration of 
the host immune response [1, 2, 94, 95]. The swIAV infec-
tion has been shown, for instance, as a way to facilitate 
the colonization of epithelial cells by S. suis, but only for 
the serotypes containing sialic-acid in their capsule [96]. 
The swIAV infection induces a loss of ciliated cells lead-
ing to the impairment of the mucociliary clearance func-
tion, but induces also the presence of the viral HA on the 
surface of infected cells that interacts with the sialic acid 
of the bacterial capsule, leading to increased adherence 
of S. suis [96, 97]. Although these swIAV effects on S. suis 
have been clearly shown in vitro, no clear in vivo impact 
of swIAV infection on S. suis pulmonary load has been 
described [98]. It was clearly shown that the presence of 
both pathogens significantly induces more inflammation 
than single infections [98, 99].
Overall, studies carried out in pigs showed that a bac-
terium-virus or a virus-bacterium coinfection frequently 
induces an aggravation of pulmonary lesions (Figure 3B) 
and a higher inflammation (Figure  2B) and immune 
response, with increased production of pro-inflamma-
tory cytokines. In many bacterium-virus and virus-bac-
terium associations, this worsened outcome seems to be 
the result of additive effects from both pathogens rather 
than a real synergy [100, 101]. However, a potentiation 
of the viral infection by bacteria can also be observed in 
other cases, such as in the M. hyopneumoniae-PRRSV 
coinfection [102]. In that case, higher amounts of PRRSV 
genomes were detected in lymphoid tissue and blood 
[102] and a slower viral clearance was observed [75] (Fig-
ure 1B), suggesting that the recruitment of immune cells 
in the lung parenchyma upon established M. hyopneu-
moniae infection may provide a steady supply of suscep-
tible cells for PRRSV [1]. Then, in porcine AMs and in 
the “African green monkey” (originally described as por-
cine origin) St-Jude Porcine Lung (SJPL) cell line, PRRSV 
infection has been shown to be blocked by a pre-infec-
tion with A. pleuropneupmoniae, this antiviral activity 
being due to the A. pleuropneumoniae metabolites [103] 
(Figure 1B). Given the fact that in vivo studies involving 
PRRSV and A. pleuropneumoniae did not always investi-
gate the impact of an A. pleuropneumoniae pre-infection 
on the subsequent PRRSV infection [104, 105], as done in 
experiments performed in  vitro [103], it cannot be eas-
ily concluded if this interference would be observed in 
the target species. However, in  vivo, PRRSV-A. pleuro-
pneumoniae interactions were reported as absent or mild 
[104, 105] (Figure 3B).
3.2.3  Bacterium–bacterium
In virus-bacterium coinfections, the dogma usually 
encountered is that viruses play an immunomodulatory 
role, which favors bacterial superinfections. Neverthe-
less, a pre-disposing effect is also described for M. hyo-
pneumoniae, which promotes viral but also bacterial 
superinfections [65] (Figure  1D). Few studies of experi-
mental coinfections or superinfections with M. hyopneu-
moniae and/or other bacteria involved in PRDC were 
performed compared to coinfections involving viruses. 
These studies are reported in Additional file  1E. Over-
all, these coinfections or superinfections induce more 
clinical signs and lung lesions and poorer technical per-
formances when compared to single infections with the 
same infectious pathogens (Figure  3C). The bacterial-
bacterial coinfections are also responsible for immune 
response alterations (for reviews see [106, 107]). For 
example, macrophages from pigs infected by M. hyo-
pneumoniae decrease their phagocytosis capacity against 
A. pleuropneumoniae [60, 65]. M. hyorhinis and M. floc-
culare, two mycoplasmas commonly co-isolated with M. 
hyopneumoniae in gross pneumonia-like lesions, may 
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also impact the immune response by inducing the cyto-
toxicity of immune cells and/or the secretion of cytokines 
affecting its outcome [108]. Co-stimulation of por-
cine BMDCs with M. hyopneumoniae and M. hyorhinis 
induces a strong IL12 production. In this last in  vitro 
model, M. hyopneumoniae associated with M. flocculare 
reduces TNFα production compared to BMDCs stimu-
lation by M. flocculare alone producing a TNFα con-
centration greater than that observed after stimulation 
with M. hyopneumoniae alone and M. hyorhinis alone 
[108]. Therefore, M. flocculare might play an initial role 
in pulmonary inflammation by inducing the produc-
tion of TNFα by resident myeloid cells. Supplementary 
investigations will be needed to elucidate the role of this 
cytokine in the pathogenesis of the disease [108]. Other 
examples of bacterium-bacterium in  vivo coinfections 
are presented in Additional file 1E.
3.3  Mechanisms of coinfections interferences
Regarding coinfections and superinfections, most stud-
ies assessed the clinical outcome of the process but less 
is known about the mechanisms of interactions between 
pathogens and the consequences for the pathogens them-
selves, the infected cells and more generally for the host.
The outcome of dual infection is variable depending on 
the antagonism, neutrality or synergy between the infec-
tious agents. On the host side, coinfection can make the 
host response ineffective, and vice versa. If we look now 
at the possible interactions that can occur between path-
ogens we have to consider the nature of the infectious 
agents (summary provided in Figure  4). Different situa-
tions can be observed and coinfections can involve virus 
with virus, bacterium with virus and vice versa, and bac-
terium with bacterium.
3.3.1  Virus–virus interactions
Regarding virus–virus interactions, consequences are 
diversified and many studies looking at virus replication 
in coinfection situations have been carried out [2]. The 
first consequence of coinfection could be the so-called 
viral interference, a situation whereby one virus interferes 
with the replication of the other one making the cells 
resistant to the superinfecting virus [109].
The most common way for viral interference is indirect 
and based on the production of type 1 and 3 IFNs which 
induce the expression of ISGs after interacting with their 
cognate receptors [110, 111]. These proteins then acti-
vate numerous mediators of the cellular antiviral system 
that may non-specifically block the replication of viruses. 
Figure 4 Consequences of the different types of coinfections for the microorganisms and for the host. In the left box some parameters 
enable to affect coinfections and superinfections are listed. IFN: Interferon, IBP: Intracellular Bacterial Pathogen.
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They may also interfere, to a certain extent, with bacterial 
multiplication since IFN can also be induced by Intra-
cellular Bacterial Pathogens (IBPs) or some extracellular 
bacteria [107, 112]. Nevertheless, in some situations type 
1 IFNs can also increase the host susceptibility to subse-
quent bacterial infection [113] through impaired mac-
rophage recruitment with a reduced CXCL1 and CXCL2 
transcription [114] and a reduced IL17 [115] production. 
Then, there is also the non-interferon-mediated viral 
interference (or intrinsic interference) which is a cellular 
state of resistance induced by the virus to new viral infec-
tion by closely related or unrelated viruses [116]. Various 
mechanisms are described to explain this cellular state of 
direct or indirect resistance (for examples see [2]). In this 
type of interference, which can occur between viruses 
but also between viruses and bacteria [107, 117], there is 
a competition between pathogens for the metabolites and 
all the host factors that allow their multiplication. Besides 
the mechanisms involving a competition for common 
cellular factors, there are also several other mechanisms 
of interference described. These relies on viral Defective 
Interfering (DI) particles [118], RNA interference (RNAi) 
[119], non-specific double stranded RNA (dsRNA) [120] 
as well as trans-acting proteins [121]. Interference can 
occur at specific steps or multiple steps of the viral rep-
lication cycle (attachment, penetration, genome repli-
cation and/or budding) and can be direct or indirect. 
Inhibition of superinfection (superinfection exclusion 
and superinfection suppression) is one of several conse-
quences that can be observed in the interference between 
related and unrelated microorganisms. In superinfection 
exclusion, an established infection interferes with a sub-
sequent, closely related infection [2, 122]. An example of 
this phenomenon in pigs is the exclusion of highly viru-
lent classical swine fever virus strain Margarita in wild 
boars persistently infected with this virus upon a chal-
lenge infection with the same Margarita strain [123]. 
Superinfection suppression is a quite close concept where 
this time persistently infected cells resist to a challenge 
with a heterologous virus [2]. Furthermore, when the 
host immune response—innate or adaptive—is consid-
ered in the study of the complex interactions taking place 
in viral coinfections, additional mechanisms of indirect 
interference linked to cellular and humoral cross-protec-
tion—resulting from a first viral contact with a wild-type 
or a vaccine strain—can be described.
Conversely, in some situations, viral coinfections can 
directly or indirectly result in enhanced replication and 
virulence for one or both pathogens as observed in sev-
eral studies involving porcine viruses [80, 83, 124–126]. 
In other cases, coinfection/superinfection has no effects 
on virus replications and the viruses can coexist in a rela-
tion called accommodation [2]. Besides consequences in 
terms of viral replication, there are also consequences 
for the genetic of the viruses and their evolution through 
events of recombination between closely related viral 
genomes. Recombination, the parameters influencing it 
and its consequences were reviewed in RNA and DNA 
viruses [127, 128]. Then, as a result of all these possible 
interactions between viruses, the severity of the resulting 
disease and its epidemiology can be altered as exempli-
fied in Additional file  1. In the pig studies, most often, 
however, the exact mechanisms controlling interactions 
between viruses were not elucidated.
3.3.2  Bacterium–virus and virus–bacterium interactions
Several mechanisms explaining bacterium–virus and 
virus–bacterium interactions have been identified (for 
reviews see [1, 94, 117]). The interactions can have 
either a positive or a negative impact on both pathogens 
depending on the bacterial and viral species involved. 
Usually, when the interactions are direct they promote 
viral infection without affecting the bacterial species [1, 
94, 117]. Examples of these direct interactions are (i) 
direct binding of the virus to a bacterium or (ii) the uti-
lization of a bacterial product by the virus. An example 
of direct interactions in the respiratory tract is the cleav-
age of the IAV HA into HA1 and HA2 by a Staphylococ-
cus aureus protease helping the viral particle to become 
infectious [129]. On the contrary, when interactions 
are indirect they often provide an advantage to bacte-
rial infections. Four mechanisms dealing with indirect 
interactions have been described: (i) viral alteration of 
the epithelial barrier, (ii) reduction or suppression of 
the host immune response, (iii) viral alteration/displace-
ment of the microbiota, and (iv) virus-induced alteration 
of bacterial cellular receptor expression [94]. All these 
mechanisms can operate together for the benefit of the 
superinfecting bacteria. A typical example of these indi-
rect interactions is provided by PCV2 and swIAV and 
porcine pathogenic bacteria such as A. pleuropneumo-
niae [130] and S. suis [96, 97, 131] where the bacteria 
benefit from the prior viral infections. However, bacteria 
can also directly benefit from a previous viral infection as 
observed in a study demonstrating that Staphylococcus 
aureus was able to bind viral HA [132]. The consequence 
of that binding was an enhanced bacterial internalisation 
by two mechanisms: (i) binding to HA exposed at the 
surface of infected cells, and (ii) binding to free extracel-
lular virions.
In some other situations, non-pathogenic bacteria can 
also directly or indirectly protect the host from viral 
infection as typically observed with probiotic bacteria 
which can show antiviral activity through the binding/
capture of the viruses and/or the competition for cell 
adhesion (for a review see [117]). This type of interaction 
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has been frequently observed with enteric bacteria [117] 
and an example in pigs is the reduced infection of IPEC-
J2 cells by vesicular stomatitis virus after pre-incubation 
of the cells with multiple probiotic bacteria [133]. An 
intriguing relationship is occurring between IBP and 
viruses where metabolic reprogramming in host cells 
triggered by viruses might support or conversely limit 
coinfection by an intracellular bacterial partner (for a 
review see [107]). Different possibilities can be identified 
in that type of interaction [107]: (i) the first pathogen can 
reprogram cellular metabolism related to cellular immu-
nity and decrease the defense against the other pathogen, 
(ii) the metabolic changes triggered by the first pathogen 
can facilitate the adhesion, the penetration, and the rep-
lication of the other, and (iii) the coinfection transform 
the active replicative state of the first pathogen into a 
stable persistent state. The first possibility associated to 
a decrease of the cellular defense is a commonly accepted 
mechanism [134] while the second and the third possi-
bilities are less experimentally demonstrated [107].
3.3.3  Bacterium–bacterium interactions
Looking at bacterium–bacterium interactions, they are 
extremely complex to assess because of the large diversity 
of the bacterial world and because little is known about 
the mechanisms underpinning these interactions dur-
ing infections. Moreover, it is now also clear that intes-
tinal and respiratory microbiomes affect the interactions 
between pathogenic bacteria and the porcine host [135]. 
Some examples of the complex interactions occurring 
in bacteria–bacteria coinfections are presented in Addi-
tional file 1E, but little is known about the mechanisms 
controlling these interactions. However, some mecha-
nisms were provided above and interesting reviews deal-
ing with that subject were published recently [106, 107] 
discussing the possible direct interactions between bacte-
ria—mainly chemical and physical. Indirect interactions 
between bacteria were not reviewed in these articles but 
were discussed to some extent in other review papers 
focusing on polymicrobial infections [1, 136].
3.4  Limitations of coinfection studies
The first observation coming from this review must be, 
even if several studies have been carried out on the sub-
ject, a lack of data about some specific coinfections and 
many discrepancies between studies. For instance, there 
are only a few in vivo studies about PCV2 in virus/virus 
coinfections and about PCV2 and PRRSV in virus/bac-
terium coinfections (Additional file  1 and heat maps in 
Figures 1, 2, 3). Discrepancies are not surprising because 
of the definition of coinfection is not always the same 
between studies in addition to huge variations in the 
coinfection parameters amongst studies.
In this review we focused on experimental (in vivo and 
in vitro) coinfections, it is worth to underline that these 
studies are inspired by field veterinarians and epidemiol-
ogists observations. However, the definition of epidemi-
ologist coinfection can also vary between studies. Indeed, 
in some cases there is concomitant direct identification 
of two microorganisms in the same animals, sometimes 
in the same farms, while in other cases it is just an indi-
rect identification of the microorganisms’ presence at 
some points through indirect serological assays. Moreo-
ver, as stated before, the term coinfection is sometimes 
used to describe some situations of superinfections where 
the delay can be significant.
Regarding the experimental parameters, the Multiplici-
ties Of Infection (MOI), the strains, the potential delays 
between successive infections, the routes of inocula-
tions, the types of cellular hosts considered (more or less 
susceptible to one of the microorganism), the genetic 
background (breeds) and the sanitary status (specific 
pathogen free or conventional breeding) of the pigs, and 
the readout to assess coinfection outcome varied a lot 
between studies. To fully compare studies, a standardi-
zation of the assays would be needed. Interestingly also, 
whereas in  vitro studies’ usefulness is not in question, 
it is important to underline here that in  vitro observed 
interplay between pathogens cannot be automatically 
applied in  vivo. For instance, whereas M. hyopneumo-
niae decreases the PRRSV titre in vitro [75], it increases 
PRRSV shedding in  vivo and indeed worsens the clini-
cal signs upon coinfection [102]. Consequently, the use 
of intermediary settings, such as co-culture of differ-
ent cell types (see [2] for examples), Precision Cut Lung 
Slices (PCLS) [137] or organoids [138], could help to 
understand the complexity of coinfections in the respira-
tory tissue. In  vitro approaches usually consider one or 
a few cell types with some limitations during the evalu-
ation process of the coinfection consequences. Some 
viruses can contribute to the elimination of other viruses 
just because of their ability to replicate faster on a par-
ticular cell type [139]. Thus, results obtained in vitro can-
not mimic the field situation when both agents coinfect 
the same pig, providing inaccurate conclusions about the 
coinfection dynamics. Under such circumstances, patho-
gens may simply have different host cells and no longer 
be under direct competition for resources [140]. Besides 
the different interactions that infecting agents can have 
between them through a competition to resources, 
studies showed clearly that the immune system and the 
immunological responses can highly affect these inter-
actions by inducing the competitive power of a patho-
gen or abolishing it and making it less competitive on 
the resource [141, 142]. The effects of the immune sys-
tem (especially humoral parameters) are often not taken 
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into consideration in selected in vitro models [140]. On 
the other hand, in  vivo coinfection experiments have 
to deal with numerous constraints (health status of the 
animals used, cost, husbandry, and ethics amongst oth-
ers) and therefore are not always easy to perform. Hence, 
although in  vivo experiments are required in this very 
complex field, they surely need to be combined to in 
silico/in vitro/ex vivo analyses of potential interactions 
between pathogens. Moreover, multiple parameters of 
the coinfection protocols appeared difficult to set with-
out any a priori such as the choice of the pathogen that 
will be inoculated first and the delay between infections. 
One possibility to deal with multiple parameters is to use 
intra-host infection mathematical modelling [143] allow-
ing to play, at limited cost, with the different parameters 
of the coinfections. However, these models need to be fed 
with data coming from conventional in vitro experiments 
as well as more complex in vivo studies. The other possi-
bility is to rely on field prevalence studies monitoring the 
very presence of the pathogens (isolation, PCR) instead 
of the sero-conversion, in order to have a clear epidemio-
logical picture of when and where coinfections occur.
Consequently, ex vivo models such as PCLS generated 
from freshly sacrificed pigs [137] or organoids [138] are 
developing. These models are closer to mimic the in vivo 
situation than usual in vitro approaches, combining dif-
ferent types of cells and providing the pathogens with a 
wider range of cell hosts. However, the contribution of 
the immune response to the interaction between differ-
ent pathogens is rarely considered [97]. Furthermore, 
the MOI cannot be controlled because the number of 
infected cells in the slice or the organoid cannot be moni-
tored easily either.
Another limiting factor in coinfection studies is the cell 
regeneration, which can vary between in vivo and in vitro 
models. Cell regeneration can highly affect the dynamics 
of a coinfection, giving some pathogens extra target cells 
guarantying their longer existence while contributing 
to the clearance of others [140]. Finally, other potential 
technical limitations could always be discussed such as 
the lack of precision or sensitivity in the different diag-
nostic techniques especially in the presence of multiple 
agents. Hence, the detection of coinfecting pathogens 
could be compromised or reduced as compared to their 
detection level in the context of single infections.
4  Conclusion and perspectives
As shown in this review many works have been dedi-
cated to the study of coinfections and superinfections 
in pigs. Usually, when the experiments were carried 
out in  vivo, the researchers were more interested in 
the clinical outcome than in the interactions occurring 
between pathogens. Indeed, in most of the cases the 
fine interactions between pathogens and especially the 
mechanisms behind these interactions and its potential 
consequences, at the molecular level, on the immune 
response were not studied for several reasons including 
technical limitations. Also, in the studies assessing the 
occurrence of coinfections/superinfections in the fields, 
coinfection identification based on molecular tools such 
as PCR would be more accurate than sero-prevalence 
approaches which are less prone to identify currently 
present pathogens and thus coinfective pathogens. Then, 
a better knowledge of each pathogen involved is crucial. 
We thus would like to make recommendations for future 
studies dealing with respiratory coinfections in pigs: (i) 
Authors should clearly summarize their coinfection or 
superinfection experimental setup—doses of pathogens, 
delays between infections—in their Materials and meth-
ods section; (ii) in this summary they would need to 
clearly present the pathogens they use and they should, 
as often as possible, select well-characterized strains; (iii) 
environmental and management conditions would need 
a strict control and monitoring; (iv) animal genetic and 
sanitary status would need to be carefully described and 
monitored during the study; and (v) the multiplications 
of all the pathogens shall be followed during the experi-
ment using highly sensitive and specific assays. A clear 
description of all these parameters would help the sci-
entific community to compare studies and progress in 
the understanding of the complex interactions between 
microorganisms.
In the last years, the concept of innate immune 
memory or trained immunity has gained a lot of inter-
est. This concept is coming from old observation, in 
1946 [144], recognizing that the bacterial vaccine strain 
“Bacille de Calmette et Guérin” (BCG) was protecting 
not only against Mycobacterium tuberculosis but also 
against antigenically different microorganism causing 
childhood mortality, suggesting an “adaptation” of the 
cellular innate immune system. Since then, many inter-
esting studies about innate immune memory or trained 
immunity have been published (for a review see [145]) 
and it is recognized that cells such as myeloid cells, NK 
cells, and even epithelial cells [146] can have a higher 
and quicker response upon re-exposure to a pathogen. 
Trained immunity is accompanied by epigenetic changes 
and most often associated with modifications in cellular 
metabolism. A close look at potential epigenetic changes 
and cellular metabolism modifications would be of high 
interest in respiratory coinfection studies in the porcine 
species. Recently an alternative to the mechanism of 
trained immunity in resident lung innate immune cells 
named “epigenetic legacy” has been described [147]. In 
that study, the authors demonstrated that following IAV 
clearance and clinical recovery (1-month post-infection), 
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mice were better protected from Streptococcus pneumo-
niae infection by adult bone-marrow-derived AMs dis-
playing transient transcriptional and epigenetic distinct 
profiles. This newly described consequence of a first viral 
infection also needs additional studies about PRDC with 
an identification of the mechanisms shaping the complex 
interactions between pathogens.
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